Natural Health Trends (NHTC) 10-Q 1 Aug 18 2018 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Jul. 27, 2018
Document And Entity Information
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Entity Registrant Name	NATURAL HEALTH TRENDS CORP.
Entity Central Index Key	912,061
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding (in shares)		11,376,092
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q2
Amendment Flag	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 128,270	$ 135,311
Inventories	10,358	8,398
Other current assets	5,550	7,534
Total current assets	144,178	151,243
Property and equipment, net	1,025	1,149
Goodwill	1,764	1,764
Restricted cash	3,111	3,167
Deferred Tax Assets, Net, Current	1,435	1,435
Other assets	854	796
Total assets	152,367	159,554
Current liabilities:
Accounts payable	2,995	1,751
Income taxes payable	257	309
Accrued commissions	10,399	11,170
Other accrued expenses	8,157	7,605
Deferred revenue	3,831	4,455
Amounts held in eWallets	14,902	15,152
Other current liabilities	1,446	1,479
Total current liabilities	41,987	41,921
Accrued Income Taxes, Noncurrent	17,395	19,052
Deferred Tax Liabilities, Net, Noncurrent	75	56
Long-term incentive	7,342	7,904
Total liabilities	66,799	68,933
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at June 30, 2018 and December 31, 2017	13	13
Additional paid-in capital	86,415	86,683
Retained earnings	39,662	44,908
Accumulated other comprehensive loss	(774)	(413)
Treasury stock, at cost; 1,603,322 and 1,637,524 shares at June 30, 2018 and December 31, 2017, respectively	(39,748)	(40,570)
Total stockholders’ equity	85,568	90,621
Total liabilities and stockholders’ equity	$ 152,367	$ 159,554

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	12,979,414	12,979,414
Treasury stock, shares	1,603,322	1,637,524

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Net sales	$ 50,910	$ 51,465	$ 103,277	$ 111,339
Cost of sales	10,399	9,793	20,620	21,038
Gross profit	40,511	41,672	82,657	90,301
Operating expenses:
Commissions expense	22,310	22,075	45,290	48,040
Selling, general and administrative expenses	8,093	6,730	17,215	16,402
Total operating expenses	30,403	28,805	62,505	64,442
Income from operations	10,108	12,867	20,152	25,859
Other income, net	53	80	216	236
Income before income taxes	10,161	12,947	20,368	26,095
Income tax provision	1,138	2,644	2,521	5,367
Net income	$ 9,023	$ 10,303	$ 17,847	$ 20,728
Net income per common share:
Basic (in dollars per share)	$ 0.80	$ 0.92	$ 1.58	$ 1.84
Earnings Per Share, Diluted	$ 0.80	$ 0.91	$ 1.58	$ 1.84
Weighted-average number of common shares outstanding:
Basic (in shares)	11,298	11,243	11,292	11,236
Diluted (in shares)	11,305	11,274	11,297	11,264
Cash dividends declared per share:
Common (in dollars per share)	$ 1.90	$ 0.45	$ 2.03	$ 0.89

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Statement of Comprehensive Income [Abstract]
Net income	$ 9,023	$ 10,303	$ 17,847	$ 20,728
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(762)	87	(365)	163
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax	0	0	0	(258)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(762)	87	(365)	(95)
Unrealized gains (losses) on available-for-sale securities	15	2	4	(5)
Comprehensive income	$ 8,276	$ 10,392	$ 17,486	$ 20,628

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 17,847	$ 20,728
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	235	276
Stock-based compensation	0	17
Cumulative Translation Adjustment Realized In Net Income	0	(258)
Changes in assets and liabilities:
Inventories	(2,057)	1,388
Other current assets	1,955	489
Other assets	(73)	(58)
Accounts payable	1,246	226
Income taxes payable	(1,705)	4,304
Accrued commissions	(707)	(915)
Other accrued expenses	1,119	(3,229)
Deferred revenue	(592)	(939)
Amounts held in eWallets	(192)	(327)
Other current liabilities	(24)	(24)
Long-term incentive	(562)	(1,049)
Net cash provided by operating activities	16,490	20,629
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(113)	(170)
Net cash used in investing activities	(113)	(170)
CASH FLOWS FROM FINANCING ACTIVITIES:
Dividends paid	(23,093)	(10,078)
Net cash used in financing activities	(23,093)	(10,078)
Effect of exchange rates on cash, cash equivalents and restricted cash	(381)	(41)
Net (decrease) increase in cash, cash equivalents and restricted cash	(7,097)	10,340
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period	138,478	128,884
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period	131,381	139,224
SUPPLEMENTAL DISCLOSURES OF OTHER CASH FLOW INFORMATION:
Issuance of treasury stock for employee awards, net	$ 554	$ 1,393

NATURE OF OPERATIONS AND BASIS

NATURE OF OPERATIONS AND BASIS OF PRESENTATION	6 Months Ended
	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS AND BASIS OF PRESENTATION	NATURE OF OPERATIONS, BASIS OF PRESENTATION AND CONSOLIDATION Nature of Operations Natural Health Trends Corp., a Delaware corporation (whether or not including its subsidiaries, the “Company”), is an international direct-selling and e-commerce company headquartered in Rolling Hills Estates, California. Subsidiaries controlled by the Company sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. The Company’s wholly-owned subsidiaries have an active physical presence in the following markets: the Americas, which consists of the United States, Canada, Cayman Islands, Mexico and Peru; Greater China, which consists of Hong Kong, Taiwan and China; Southeast Asia, which consists of Singapore, Malaysia and Vietnam; South Korea; Japan; and Europe. The Company also operates in Russia and Kazakhstan through an engagement with a local service provider. Basis of Presentation The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s 2017 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (SEC) on March 27, 2018. Principles of Consolidation The consolidated financial statements include the accounts of the Company and all of its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. Reclassification In accordance with the adoption of Accounting Standards Update (“ASU”) No. 2016-18, Statement of Cash Flows - Restricted Cash

ACCOUNTING PRONOUNCEMENTS ACCOU

ACCOUNTING PRONOUNCEMENTS ACCOUNTING PRONOUNCEMENTS (Notes)	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	ACCOUNTING PRONOUNCEMENTS In November 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-18 that requires amounts generally described as restricted cash or restricted cash equivalents be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases , that requires organizations that lease assets, referred to as “lessees”, to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 will also require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The new standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those annual years, and early application is permitted. The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In May 2014, the FASB issued ASU No. 2014-09, Revenue From Contracts With Customers , that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. It also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities had the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. In July 2015, the FASB approved the deferral of the effective date for annual reporting periods that began after December 15, 2017, including interim reporting periods. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. See Note 3 for additional information.

REVENUE Revenue (Notes)

REVENUE Revenue (Notes)	6 Months Ended
	Jun. 30, 2018
Revenue Recognition [Abstract]
Revenue [Text Block]	REVENUE Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers , which was adopted on January 1, 2018 using the modified retrospective method. All revenue is recognized when the performance obligations under a contract are satisfied. Product sales are recognized when the products are shipped and title passes to independent members. Product sales to members are made pursuant to a member agreement that provides for transfer of both title and risk of loss upon the Company’s delivery to the carrier that completes delivery to the members, which is commonly referred to as “F.O.B. Shipping Point.” The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return. These contracts are generally short-term in nature. Actual product returns are recorded as a reduction to net sales. The Company estimates and accrues a reserve for product returns based on its return policies and historical experience. The reserve is based upon the return policy of each country, which varies from 14 days to one year, and their historical return rates, which range from 1% to 7% of sales. Sales returns were 2% and 3% of sales for the six months ended June 30, 2018 and 2017 , respectively. No material changes in estimates have been recognized during the periods presented. See Note 5 for additional information. The Company has elected to account for shipping and handling activities performed after title has passed to members as a fulfillment cost, and accrues for the costs of shipping and handling if revenue is recognized before the contractually obligated shipping and handling activities occurs. Shipping charges billed to members are included in net sales. Costs associated with shipments are included in cost of sales. Event and training revenue is deferred and recognized as the event or training occurs. Costs of events and member training are included within selling, general and administrative expenses. Various taxes on the sale of products to members are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. Deferred Revenue The Company primarily receives payment by credit card at the time members place orders. Amounts received for unshipped product are considered a contract liability and are recorded as deferred revenue. The decrease in deferred revenue for the three months ended June 30, 2018 is primarily due to $2.8 million of revenue recognized which was included in deferred revenue as of March 31, 2018, offset by cash payments received or due in advance of satisfying the Company’s performance obligations. See Note 5 for additional information. Disaggregation of Revenue The Company sells products to a member network that operates in a seamless manner from market to market, except for the Chinese market where it sells to consumers through an e-commerce retail platform and the Russia and Kazakhstan market where the Company operates through an engagement of a third-party service provider. The following table sets forth revenue by market for the periods indicated (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2018 2017 2018 2017 Americas 1 $ 1,855 3.6 % $ 1,641 3.2 % $ 3,391 3.3 % $ 3,101 2.8 % Hong Kong 2 44,615 87.7 45,688 88.8 92,234 89.3 100,255 90.0 China 2,553 5.0 1,247 2.4 3,812 3.7 3,001 2.7 Taiwan 937 1.8 1,729 3.4 1,998 1.9 2,887 2.6 South Korea 140 0.3 129 0.2 259 0.3 251 0.2 Japan 44 0.1 33 0.1 109 0.1 60 0.1 Singapore 51 0.1 39 0.1 82 0.1 84 0.1 Malaysia 57 0.1 — — 100 0.1 — — Russia and Kazakhstan 239 0.5 229 0.4 442 0.4 446 0.4 Europe 419 0.8 730 1.4 850 0.8 1,254 1.1 Total $ 50,910 100.0 % $ 51,465 100.0 % $ 103,277 100.0 % $ 111,339 100.0 % 1 United States, Canada, Mexico and Peru 2 Substantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. See “Item 1A. Risk Factors” in our most recent Annual Report on Form 10-K. The Company’s net sales by product and service are as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2018 2017 2018 2017 Product sales $ 48,458 $ 49,528 $ 97,823 $ 106,105 Freight and other 3,434 3,179 7,186 7,815 Less: sales returns (982 ) (1,242 ) (1,732 ) (2,581 ) Total net sales $ 50,910 $ 51,465 $ 103,277 $ 111,339 Concentration No single market other than Hong Kong had net sales greater than 10% of total net sales and no single customer accounted for 10% or more of net sales for the three and six months ended June 30, 2018 and 2017 . The Company’s business model can result in a concentration of sales to several different members and their network of members. Although no single member accounted for 10% or more of net sales, the loss of a key member or that member’s network could have an adverse effect on the Company’s net sales and financial results. Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenues to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged for individual products to similar customers. Practical Expedients The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded in commissions expense.

NET INCOME PER COMMON SHARE NET

NET INCOME PER COMMON SHARE NET INCOME PER COMMON SHARE	6 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NET INCOME PER COMMON SHARE Diluted net income per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares. The following tables illustrate the computation of basic and diluted net income per common share for the periods indicated (in thousands, except per share data): Three Months Ended June 30, 2018 2017 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic net income per common share: Net income available to common stockholders $ 9,023 11,298 $ 0.80 $ 10,303 11,243 $ 0.92 Effect of dilutive securities: Non-vested restricted stock — 7 — 31 Diluted net income per common share: Net income available to common stockholders plus assumed conversions $ 9,023 11,305 $ 0.80 $ 10,303 11,274 $ 0.91 Six Months Ended June 30, 2018 2017 Income Shares Per Share Amount Income Shares Per Share Amount Basic net income per common share: Net income available to common stockholders $ 17,847 11,292 $ 1.58 $ 20,728 11,236 $ 1.84 Effect of dilutive securities: Non-vested restricted stock — 5 — 28 Diluted net income per common share: Net income available to common stockholders plus assumed conversions $ 17,847 11,297 $ 1.58 $ 20,728 11,264 $ 1.84 Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to be vested. Non-vested restricted stock totaling 11,030 and 13,331

BALANCE SHEET COMPONENTS Balanc

BALANCE SHEET COMPONENTS Balance Sheet Components	6 Months Ended
	Jun. 30, 2018
Balance Sheet Components [Abstract]
Supplemental Balance Sheet Disclosures [Text Block]	BALANCE SHEET COMPONENTS The components of certain balance sheet amounts are as follows (in thousands): June 30, 2018 December 31, 2017 Cash, cash equivalents and restricted cash: Cash $ 51,124 $ 61,703 Cash equivalents 77,146 73,608 128,270 135,311 Restricted cash 3,111 3,167 $ 131,381 $ 138,478 Inventories: Finished goods $ 9,852 $ 7,779 Raw materials 574 799 Inventory reserve for obsolescence (68 ) (180 ) $ 10,358 $ 8,398 Other accrued expenses: Sales returns $ 455 $ 614 Employee-related expense 6,069 5,568 Warehousing, inventory-related and other 1,633 1,423 $ 8,157 $ 7,605 Deferred revenue: Unshipped product $ 1,703 $ 2,411 Auto ship advances 1,752 1,665 Other 376 379 $ 3,831 $ 4,455

FAIR VALUE MEASUREMENTS (Notes)

FAIR VALUE MEASUREMENTS (Notes)	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	FAIR VALUE MEASUREMENTS As of June 30, 2018 , cash and cash equivalents include the Company’s investments in debt securities, comprising municipal notes and bonds and corporate debt, commercial paper, money market funds and time deposits. The Company considers all highly liquid investments with original maturities of three months or less when purchased and have insignificant interest rate risk to be cash equivalents. Debt securities classified as cash equivalents are required to be accounted for in accordance with ASC 320, Investments - Debt and Equity Securities . As such, the Company determined its investments in debt securities held at June 30, 2018 should be classified as available-for-sale and are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income in stockholders’ equity. The cost of debt securities is adjusted for amortization of premiums and discounts to maturity. This amortization is included in other income. Realized gains and losses, as well as interest income, are also included in other income. The fair values of securities are based on quoted market prices. The carrying amounts of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximate fair value because of their short maturities. The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents. The Company’s cash equivalents are valued based on level 1 inputs which consist of quoted prices in active markets. Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value. The Company has elected to not fair value existing eligible items. Available-for-sale investments included in cash equivalents at the end of each period were as follows (in thousands): June 30, 2018 December 31, 2017 Adjusted Cost Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Losses Fair Value Municipal bonds and notes $ 7,176 $ (1 ) $ 7,175 $ 13,320 $ (1 ) $ 13,319 Corporate debt securities 49,900 (22 ) 49,878 49,432 (24 ) 49,408 Financial institution instruments 20,093 — 20,093 10,881 — 10,881 Total available-for-sale investments $ 77,169 $ (23 ) $ 77,146 $ 73,633 $ (25 ) $ 73,608

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	STOCKHOLDERS’ EQUITY Dividends The following table summarizes the Company’s cash dividend activity for the six months ended June 30, 2018 (in thousands, except per share data): Declaration Date Per Share Amount Record Date Payment Date April 17, 2018 (special) $ 1.76 $ 20,022 May 15, 2018 May 25, 2018 April 17, 2018 0.14 1,592 May 15, 2018 May 25, 2018 February 6, 2018 0.13 1,479 February 27, 2018 March 9, 2018 $ 2.03 $ 23,093 Declaration and payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors. Stock Repurchases On January 12, 2016, the Board of Directors authorized an increase to the Company’s stock repurchase program first approved on July 28, 2015 from $15.0 million to $70.0 million . Repurchases are expected to be executed to the extent that the Company’s earnings and cash-on-hand allow, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. For all or a portion of the authorized repurchase amount, the Company may enter into one or more plans that are compliant with Rule 10b5-1 of the Exchange Act that are designed to facilitate these purchases. The stock repurchase program does not require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued. As of June 30, 2018 , $32.0 million of the $70.0 million stock repurchase program approved on July 28, 2015 and increased on January 12, 2016 remained available for future purchases, inclusive of related estimated income tax. Restricted Stock No stock-based compensation was recognized for the three or six months ended June 30, 2018 . Stock-based compensation expense totaled $8,600 and $17,300 for the three and six months ended June 30, 2017 , respectively. At the Company’s annual meeting of stockholders held on April 7, 2016, the Company’s stockholders approved the Natural Health Trends Corp. 2016 Equity Incentive Plan (the “2016 Plan”) to replace its 2007 Equity Incentive Plan. The 2016 Plan allows for the grant of various equity awards including incentive stock options, non-statutory options, stock, stock units, stock appreciation rights and other similar equity-based awards to the Company’s employees, officers, non-employee directors, contractors, consultants and advisors of the Company. Up to 2,500,000 shares of the Company’s common stock (subject to adjustment under certain circumstances) may be issued pursuant to awards granted. At June 30, 2018 , 2,359,671 shares remained available for issuance under the 2016 Plan. On February 1, 2018, the Company granted 34,202 shares of restricted common stock under the 2016 Plan to certain employees for the purpose of further aligning their interest with those of its stockholders and settling fiscal 2017 performance incentives totaling $554,000 . The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances. The following table summarizes the Company’s restricted stock activity under the 2016 Plan: Shares Wtd. Avg. Price at Date of Issuance Nonvested at December 31, 2017 58,032 $ 28.59 Granted 34,202 16.19 Vested (23,374 ) 26.31 Nonvested at June 30, 2018 68,860 23.20 Accumulated Other Comprehensive Loss The changes in accumulated other comprehensive loss by component for the first six months of 2018 were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Gains/(Losses) on Available-For-Sale Investments Total Balance, December 31, 2017 $ (386 ) $ (27 ) $ (413 ) Other comprehensive income (loss) (365 ) 4 (361 ) Balance, June 30, 2018 $ (751 ) $ (23 ) $ (774 )

INCOME TAXES INCOME TAXES

INCOME TAXES INCOME TAXES	6 Months Ended
	Jun. 30, 2018
INCOME TAXES [Abstract]
Income Tax, Policy [Policy Text Block]	INCOME TAXES The effective income tax rate for the three and six months ended June 30, 2018 was significantly impacted by recording the effect of the Tax Cuts and Jobs Act (the “Tax Act”), enacted on December 22, 2017 by the U.S. government. The Tax Act makes broad and complex changes to the Internal Revenue Code of 1986, as amended, which affected the Company’s year ended December 31, 2017, including, but not limited to, reducing the maximum U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018, and requiring a one-time repatriation tax on certain un-repatriated earnings of foreign subsidiaries at a rate of 15.5% tax on post-1986 foreign earnings held in cash and an 8% rate on all other post-1986 earnings, which is payable over eight years beginning with 8% of the liability due with the filing of the year ended December 31, 2017 federal tax return that will be due in 2018. On December 22, 2017, the Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740, Income Taxes . In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Tax Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate to be included in the financial statements. If a company cannot determine a provisional estimate to be included in the financial statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws that were in effect immediately before the enactment of the Tax Act. While the Company is able to make reasonable estimates of the impact of the reduction in the corporate income tax rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from these estimates, due to, among other things, changes in the Company’s interpretations and assumptions, additional guidance that may be issued by the Internal Revenue Service, and actions it may take. The Company is continuing to gather additional information to determine the final impact. Any adjustments recorded to the provisional amounts through the fourth quarter of 2018 will be included as an adjustment to income tax expense. Effective January 1, 2018, the Company is subject to the new Global Intangible Low-Taxed Income (“GILTI”) tax rules. GILTI is the excess income of foreign subsidiaries over a 10% routine return on tangible assets. After a 50% deduction, GILTI is subject to the 21% corporate tax rate. Due to the complexity of the GILTI tax rules, the Company continues to evaluate this provision of the Tax Act and the application of ASC 740. Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current period expense when incurred (the “period cost method”) or factoring such amounts into the Company’s measurement of its deferred taxes (the “deferred method”). Although the Company has not elected an accounting policy, it has recorded a provisional amount of the GILTI tax as a current period expense for 2018. The impact of GILTI as a component of the effective tax rate for the six months ended June 30, 2018 was approximately 8%, or $1.6 million , net of foreign tax credits attributed to GILTI. The provisional amount of the GILTI tax during the second quarter of 2018 resulted in a decrease as a component of the effective tax rate from 10% in the first quarter of 2018. The Company will determine the appropriate accounting policy for its structure and record any necessary adjustments within the measurement period. As a result of capital return activities, the Company determined that a portion of its current undistributed foreign earnings are no longer deemed reinvested indefinitely by its non-U.S. subsidiaries. For state income tax purposes, the Company will continue to periodically reassess the needs of its foreign subsidiaries and update its indefinite reinvestment assertion as necessary. Due to the adoption of a territorial tax regime upon the enactment of the Tax Act, any foreign source portion of a qualified dividend received by a 10% U.S. corporate shareholder is exempt from U.S. federal tax, therefore resulting in any future repatriation having a minimal effect on the Company’s effective tax rate. To the extent that additional foreign earnings are not deemed permanently reinvested, the Company expects to recognize additional income tax provision at the applicable U.S. state corporate tax rate(s). As of June 30, 2018 , the Company has accrued tax liabilities for earnings that it plans to repatriate out of accumulated earnings in future periods for state tax purposes only. All undistributed earnings in excess of 50% of current earnings on an annual basis are intended to be reinvested indefinitely as of June 30, 2018 .

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Securities Class Action In January 2016, two putative securities class action complaints were filed against the Company and its top executives in the United States District Court for the Central District of California. On March 29, 2016, the court consolidated these actions under the caption Ford v. Natural Health Trends Corp., Case No. 2:16-cv-00255-TJH-AFMx, appointed two Lead Plaintiffs, Mahn Dao and Juan Wang, and appointed the Rosen Law Firm and Levi & Korsinsky LLP as co-Lead Counsel for the purported class. On April 2, 2018, the court approved a class-wide settlement of the action in the amount of $1.75 million , which was fully funded by the Company’s insurers. On April 6, 2018, the court entered a Final Judgment and Order of Dismissal With Prejudice. Shareholder Derivative Claims In February 2016, a purported shareholder derivative complaint was filed in the Superior Court of the State of California, County of Los Angeles: Zhou v. Sharng . In March 2016, a purported shareholder derivative complaint was filed in the United States District Court for the Central District of California: Kleinfeldt v. Sharng (collectively the “Derivative Complaints”). The Derivative Complaints purport to assert claims for breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement and corporate waste against certain of the Company’s officers and directors. The Derivative Complaints also purport to assert fiduciary duty claims based on alleged insider selling and conspiring to enter into several stock repurchase agreements, which allegedly harmed the Company and its assets. The Derivative Complaints allege, among other things, that the Company has been running an allegedly illegal multilevel marketing business in China, and it has made materially false and misleading statements regarding the legality of its business operations in China, and that certain officers and directors sold common stock on the basis of this allegedly material, adverse non-public information. The Derivative Complaints seek an indeterminate amount of damages, plus interest and costs, as well as various equitable remedies. On February 1, 2017, pursuant to a stipulation among the parties, the Los Angeles Superior Court entered a stay of the Zhou action pending conclusion of the related federal class action in the United States District Court for the Central District of California: Ford v. Natural Health Trends Corp. A nearly identical stipulated stay was entered in the Kleinfeldt case on February 28, 2017. On November 10, 2017, the parties to both the Zhou and Kleinfeldt actions entered into a Memorandum of Understanding (“MOU”) to resolve both actions, subject to the negotiation of a written settlement agreement and approval by the federal court in the Kleinfeldt matter. On November 15, 2017, the parties filed a joint status report and stipulation in the Zhou matter, alerting the court to the MOU and seeking to maintain the stay pending finalization and court approval of the parties’ tentative settlement. The Zhou court entered an order continuing the stay on November 17, 2017. On March 9, 2018, the parties filed a Stipulation of Settlement and supporting papers in the Kleinfeldt action. On March 22, 2018, plaintiffs filed a motion for preliminary approval of the tentative settlement. On April 4, 2018, the court entered an order preliminarily approving the proposed settlement and setting a final hearing for July 16, 2018. On July 16, 2018, the court granted final approval of the settlement and entered judgment in the Kleinfeldt matter. In exchange for full releases, the settlement requires the Company to implement certain corporate governance reforms and includes an award of $250,000 in attorneys’ fees to plaintiffs’ counsel, all of which will be fully funded by the Company’s insurers. The settlement and judgment also requires that plaintiff take the necessary steps to voluntarily dismiss the Zhou action with prejudice promptly after the judgment becomes final and non-appealable. Other Claims

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2018
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS In February 2013, the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C., a Texas limited liability company, (“BHS”) regarding the manufacture and sale of a product called ReStor™ . George K. Broady, a director of the Company and beneficial owner of more than 5% of its outstanding common stock, is owner of BHS. Under the agreement, the Company agreed to pay BHS a royalty of 2.5% of sales revenue in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide, with certain rights being exclusive outside the United States. On April 29, 2015, the Company and BHS amended the Royalty Agreement and License to change the royalty to a price per unit instead of 2.5% of sales revenue. Such provision was effective retroactively to January 1, 2015. Such royalties were $93,000 and $86,000 for the three months ended June 30, 2018 and 2017 , respectively, and $176,000 and $177,000 for the six months ended June 30, 2018 and 2017 , respectively. The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days ’ notice or, under certain circumstances, with no

SUBSEQUENT EVENT

SUBSEQUENT EVENT	6 Months Ended
	Jun. 30, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENT	SUBSEQUENT EVENT On July 18, 2018 , the Board of Directors declared a quarterly cash dividend of $0.15 and a special cash dividend of $0.25 on each share of common stock outstanding. Such dividends are payable on August 24, 2018 to stockholders of record on August 14, 2018

NATURE OF OPERATIONS, BASIS OF

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND CONSOLIDATION CONSOLIDATION	6 Months Ended
	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation	Principles of Consolidation

ACCOUNTING PRONOUNCEMENTS ACC19

ACCOUNTING PRONOUNCEMENTS ACCOUNTING PRONOUNCEMENTS	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	ACCOUNTING PRONOUNCEMENTS In November 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-18 that requires amounts generally described as restricted cash or restricted cash equivalents be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases , that requires organizations that lease assets, referred to as “lessees”, to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 will also require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The new standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those annual years, and early application is permitted. The Company is currently assessing the impact that this standard will have on its consolidated financial statements. In May 2014, the FASB issued ASU No. 2014-09, Revenue From Contracts With Customers , that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. It also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities had the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. In July 2015, the FASB approved the deferral of the effective date for annual reporting periods that began after December 15, 2017, including interim reporting periods. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. See Note 3 for additional information.

REVENUE Revenue Recognition (Po

REVENUE Revenue Recognition (Policies)	6 Months Ended
	Jun. 30, 2018
Revenue Recognition [Abstract]
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers , which was adopted on January 1, 2018 using the modified retrospective method. All revenue is recognized when the performance obligations under a contract are satisfied. Product sales are recognized when the products are shipped and title passes to independent members. Product sales to members are made pursuant to a member agreement that provides for transfer of both title and risk of loss upon the Company’s delivery to the carrier that completes delivery to the members, which is commonly referred to as “F.O.B. Shipping Point.” The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return. These contracts are generally short-term in nature. Actual product returns are recorded as a reduction to net sales. The Company estimates and accrues a reserve for product returns based on its return policies and historical experience. The reserve is based upon the return policy of each country, which varies from 14 days to one year, and their historical return rates, which range from 1% to 7% of sales. Sales returns were 2% and 3% of sales for the six months ended June 30, 2018 and 2017 , respectively. No material changes in estimates have been recognized during the periods presented. See Note 5 for additional information. The Company has elected to account for shipping and handling activities performed after title has passed to members as a fulfillment cost, and accrues for the costs of shipping and handling if revenue is recognized before the contractually obligated shipping and handling activities occurs. Shipping charges billed to members are included in net sales. Costs associated with shipments are included in cost of sales. Event and training revenue is deferred and recognized as the event or training occurs. Costs of events and member training are included within selling, general and administrative expenses.

NET INCOME PER COMMON SHARE N21

NET INCOME PER COMMON SHARE Net Income Per Common Share (Policies)	6 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
Earnings Per Share, Policy [Policy Text Block]	Diluted net income per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares.

FAIR VALUE MEASUREMENTS (Polici

FAIR VALUE MEASUREMENTS (Policies)	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Cash and Cash Equivalents, Policy [Policy Text Block]	As of June 30, 2018 , cash and cash equivalents include the Company’s investments in debt securities, comprising municipal notes and bonds and corporate debt, commercial paper, money market funds and time deposits. The Company considers all highly liquid investments with original maturities of three months or less when purchased and have insignificant interest rate risk to be cash equivalents. Debt securities classified as cash equivalents are required to be accounted for in accordance with ASC 320, Investments - Debt and Equity Securities . As such, the Company determined its investments in debt securities held at June 30, 2018
Fair Value of Financial Instruments, Policy [Policy Text Block]	The carrying amounts of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximate fair value because of their short maturities. The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents. The Company’s cash equivalents are valued based on level 1 inputs which consist of quoted prices in active markets.

REVENUE Revenue (Tables)

REVENUE Revenue (Tables)	6 Months Ended
	Jun. 30, 2018
Revenue Recognition [Abstract]
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2018 2017 2018 2017 Americas 1 $ 1,855 3.6 % $ 1,641 3.2 % $ 3,391 3.3 % $ 3,101 2.8 % Hong Kong 2 44,615 87.7 45,688 88.8 92,234 89.3 100,255 90.0 China 2,553 5.0 1,247 2.4 3,812 3.7 3,001 2.7 Taiwan 937 1.8 1,729 3.4 1,998 1.9 2,887 2.6 South Korea 140 0.3 129 0.2 259 0.3 251 0.2 Japan 44 0.1 33 0.1 109 0.1 60 0.1 Singapore 51 0.1 39 0.1 82 0.1 84 0.1 Malaysia 57 0.1 — — 100 0.1 — — Russia and Kazakhstan 239 0.5 229 0.4 442 0.4 446 0.4 Europe 419 0.8 730 1.4 850 0.8 1,254 1.1 Total $ 50,910 100.0 % $ 51,465 100.0 % $ 103,277 100.0 % $ 111,339 100.0 %
Revenue from External Customers by Products and Services [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2018 2017 2018 2017 Product sales $ 48,458 $ 49,528 $ 97,823 $ 106,105 Freight and other 3,434 3,179 7,186 7,815 Less: sales returns (982 ) (1,242 ) (1,732 ) (2,581 ) Total net sales $ 50,910 $ 51,465 $ 103,277 $ 111,339

NET INCOME PER COMMON SHARE N24

NET INCOME PER COMMON SHARE Net Income Per Common Share (Tables)	6 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following tables illustrate the computation of basic and diluted net income per common share for the periods indicated (in thousands, except per share data): Three Months Ended June 30, 2018 2017 Income (Numerator) Shares (Denominator) Per Share Amount Income (Numerator) Shares (Denominator) Per Share Amount Basic net income per common share: Net income available to common stockholders $ 9,023 11,298 $ 0.80 $ 10,303 11,243 $ 0.92 Effect of dilutive securities: Non-vested restricted stock — 7 — 31 Diluted net income per common share: Net income available to common stockholders plus assumed conversions $ 9,023 11,305 $ 0.80 $ 10,303 11,274 $ 0.91 Six Months Ended June 30, 2018 2017 Income Shares Per Share Amount Income Shares Per Share Amount Basic net income per common share: Net income available to common stockholders $ 17,847 11,292 $ 1.58 $ 20,728 11,236 $ 1.84 Effect of dilutive securities: Non-vested restricted stock — 5 — 28 Diluted net income per common share: Net income available to common stockholders plus assumed conversions $ 17,847 11,297 $ 1.58 $ 20,728 11,264 $ 1.84

BALANCE SHEET COMPONENTS Bala25

BALANCE SHEET COMPONENTS Balance Sheet Components (Tables)	6 Months Ended
	Jun. 30, 2018
Balance Sheet Components [Abstract]
Schedule of Additional Balance Sheet Components [Table Text Block]	The components of certain balance sheet amounts are as follows (in thousands): June 30, 2018 December 31, 2017 Cash, cash equivalents and restricted cash: Cash $ 51,124 $ 61,703 Cash equivalents 77,146 73,608 128,270 135,311 Restricted cash 3,111 3,167 $ 131,381 $ 138,478 Inventories: Finished goods $ 9,852 $ 7,779 Raw materials 574 799 Inventory reserve for obsolescence (68 ) (180 ) $ 10,358 $ 8,398 Other accrued expenses: Sales returns $ 455 $ 614 Employee-related expense 6,069 5,568 Warehousing, inventory-related and other 1,633 1,423 $ 8,157 $ 7,605 Deferred revenue: Unshipped product $ 1,703 $ 2,411 Auto ship advances 1,752 1,665 Other 376 379 $ 3,831 $ 4,455

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Available-for-sale Securities [Table Text Block]	Available-for-sale investments included in cash equivalents at the end of each period were as follows (in thousands): June 30, 2018 December 31, 2017 Adjusted Cost Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Losses Fair Value Municipal bonds and notes $ 7,176 $ (1 ) $ 7,175 $ 13,320 $ (1 ) $ 13,319 Corporate debt securities 49,900 (22 ) 49,878 49,432 (24 ) 49,408 Financial institution instruments 20,093 — 20,093 10,881 — 10,881 Total available-for-sale investments $ 77,169 $ (23 ) $ 77,146 $ 73,633 $ (25 ) $ 73,608

STOCKHOLDERS' EQUITY RESTRICTED

STOCKHOLDERS' EQUITY RESTRICTED STOCK ACTIVITY (Tables)	6 Months Ended
	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Dividends Declared [Table Text Block]	The following table summarizes the Company’s cash dividend activity for the six months ended June 30, 2018 (in thousands, except per share data): Declaration Date Per Share Amount Record Date Payment Date April 17, 2018 (special) $ 1.76 $ 20,022 May 15, 2018 May 25, 2018 April 17, 2018 0.14 1,592 May 15, 2018 May 25, 2018 February 6, 2018 0.13 1,479 February 27, 2018 March 9, 2018 $ 2.03 $ 23,093
Summary of Restricted Stock Activity	The following table summarizes the Company’s restricted stock activity under the 2016 Plan: Shares Wtd. Avg. Price at Date of Issuance Nonvested at December 31, 2017 58,032 $ 28.59 Granted 34,202 16.19 Vested (23,374 ) 26.31 Nonvested at June 30, 2018 68,860 23.20

STOCKHOLDERS' EQUITY ACCUMULATE

STOCKHOLDERS' EQUITY ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)	6 Months Ended
	Jun. 30, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive loss by component for the first six months of 2018 were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Gains/(Losses) on Available-For-Sale Investments Total Balance, December 31, 2017 $ (386 ) $ (27 ) $ (413 ) Other comprehensive income (loss) (365 ) 4 (361 ) Balance, June 30, 2018 $ (751 ) $ (23 ) $ (774 )

REVENUE Revenue (Details)

REVENUE Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenue from External Customer [Line Items]
Sales Return Rate			2.00%	3.00%
Deferred Revenue, Revenue Recognized			$ 2,800
Revenue from Contract with Customer, Including Assessed Tax	$ 50,910	$ 51,465	103,277	$ 111,339
Sales Returns, Goods (Deprecated 2018-01-31)	$ (982)	$ (1,242)	$ (1,732)	$ (2,581)
Revenue Percentage	100.00%	100.00%	100.00%	100.00%
Americas [Member]
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 1,855	$ 1,641	$ 3,391	$ 3,101
Revenue Percentage	3.60%	3.20%	3.30%	2.80%
HONG KONG
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 44,615	$ 45,688	$ 92,234	$ 100,255
Revenue Percentage	87.70%	88.80%	89.30%	90.00%
CHINA
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 2,553	$ 1,247	$ 3,812	$ 3,001
Revenue Percentage	5.00%	2.40%	3.70%	2.70%
TAIWAN, PROVINCE OF CHINA
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 937	$ 1,729	$ 1,998	$ 2,887
Revenue Percentage	1.80%	3.40%	1.90%	2.60%
KOREA, REPUBLIC OF
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 140	$ 129	$ 259	$ 251
Revenue Percentage	0.30%	0.20%	0.30%	0.20%
JAPAN
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 44	$ 33	$ 109	$ 60
Revenue Percentage	0.10%	0.10%	0.10%	0.10%
SINGAPORE
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 51	$ 39	$ 82	$ 84
Revenue Percentage	0.10%	0.10%	0.10%	0.10%
MALAYSIA
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 57	$ 0	$ 100	$ 0
Revenue Percentage	0.10%	0.00%	0.10%	0.00%
Russia and Kazakhstan [Domain]
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 239	$ 229	$ 442	$ 446
Revenue Percentage	0.50%	0.40%	0.40%	0.40%
Europe [Member]
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 419	$ 730	$ 850	$ 1,254
Revenue Percentage	0.80%	1.40%	0.80%	1.10%
Product [Member]
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 48,458	$ 49,528	$ 97,823	$ 106,105
Shipping and Handling [Member]
Revenue from External Customer [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 3,434	$ 3,179	$ 7,186	$ 7,815

NET INCOME PER COMMON SHARE N30

NET INCOME PER COMMON SHARE Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	11,030		13,331
Net Income (Loss) Available to Common Stockholders, Basic	$ 9,023	$ 10,303	$ 17,847	$ 20,728
Weighted Average Number of Shares Outstanding, Basic	11,298,000	11,243,000	11,292,000	11,236,000
Earnings Per Share, Basic	$ 0.80	$ 0.92	$ 1.58	$ 1.84
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	7,000	31,000	5,000	28,000
Net Income (Loss) Available to Common Stockholders, Diluted	$ 9,023	$ 10,303	$ 17,847	$ 20,728
Weighted Average Number of Shares Outstanding, Diluted	11,305,000	11,274,000	11,297,000	11,264,000
Earnings Per Share, Diluted	$ 0.80	$ 0.91	$ 1.58	$ 1.84

BALANCE SHEET COMPONENTS Bala31

BALANCE SHEET COMPONENTS Balance Sheet Components (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and Cash Equivalents, at Carrying Value	$ 128,270	$ 135,311
Restricted cash	3,111	3,167
Cash	131,381	138,478	$ 139,224	$ 128,884
Inventory, Finished Goods, Gross	9,852	7,779
Inventory, Raw Materials and Supplies, Gross	574	799
Inventory Valuation Reserves	(68)	(180)
Inventory, Net	10,358	8,398
Accrued Sales Returns	455	614
Accrued Employee Benefits, Current	6,069	5,568
Accrued Warehousing And Inventory Related Expense	1,633	1,423
Other Accrued Liabilities, Current	8,157	7,605
Deferred Revenue, Current	3,831	4,455
Cash [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and Cash Equivalents, at Carrying Value	51,124	61,703
Cash Equivalents [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and Cash Equivalents, at Carrying Value	77,146	73,608
Unshipped Product [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Deferred Revenue	1,703	2,411
Auto Ship Advances [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Deferred Revenue	1,752	1,665
Enrollment Package Revenue [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Deferred Revenue	$ 376	$ 379

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$ 77,169	$ 73,633
Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax	(23)	(25)
Available-for-sale Securities	77,146	73,608
Municipal Bonds and Notes [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Amortized Cost Basis	7,176	13,320
Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax	(1)	(1)
Available-for-sale Securities	7,175	13,319
Corporate Debt Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Amortized Cost Basis	49,900	49,432
Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax	(22)	(24)
Available-for-sale Securities	49,878	49,408
Financial Institution Instruments [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Amortized Cost Basis	20,093	10,881
Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax	0	0
Available-for-sale Securities	$ 20,093	$ 10,881

STOCKHOLDERS' EQUITY NARRATIVE

STOCKHOLDERS' EQUITY NARRATIVE (Details) - USD ($)	Apr. 17, 2018	Feb. 06, 2018	Feb. 01, 2018	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Apr. 07, 2016	Jan. 12, 2016	Jul. 28, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Dividends, Per Share, Declared	$ 0.14	$ 0.13		$ 1.90	$ 0.45	$ 2.03	$ 0.89
CommonStockSpecialDividendsPerShareDeclared	$ 1.76
Share-based compensation expense					$ 8,600		$ 17,300
Stock repurchase program, amount authorized									$ 70,000,000	$ 15,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount				$ 32,000,000		$ 32,000,000
Common Stock, Dividends, Per Share, Cash Paid						$ 2.03
Dividends, Common Stock, Cash	$ 20,022,000
Dividends, Cash	$ 1,592,000	$ 1,479,000				$ 23,093,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			34,202
Award vesting period (in years)			3 years
Equity Incentive Plan 2016 | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized								2,500,000
Equity Incentive Plan 2016 | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)						34,202

STOCKHOLDERS' EQUITY RESTRICT34

STOCKHOLDERS' EQUITY RESTRICTED STOCK ACTIVITY (Details) - USD ($)	Feb. 01, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense		$ 8,600		$ 17,300
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			2,359,671
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 554,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	34,202
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Restricted Stock | Equity Incentive Plan 2016
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Nonvested, beginning balance (in shares)			58,032
Granted (in shares)			34,202
Vested (in shares)			(23,374)
Nonvested, ending balance (in shares)			68,860
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested, beginning balance (in dollars per share)			$ 28.59
Granted (in dollars per share)			16.19
Vested (in dollars per share)			26.31
Nonvested, ending balance (in dollars per share)			$ 23.20

STOCKHOLDERS' EQUITY ACCUMULA35

STOCKHOLDERS' EQUITY ACCUMULATED OTHER COMPREHENSIVE LOSS (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2018USD ($)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, December 31, 2017	$ (413)
Balance, June 30, 2018	(774)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, December 31, 2017	(386)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(365)
Balance, June 30, 2018	(751)
Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, December 31, 2017	(27)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	4
Balance, June 30, 2018	(23)
AOCI Attributable to Parent [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance, December 31, 2017	(413)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(361)
Balance, June 30, 2018	$ (774)

INCOME TAXES NARRATIVE (Details

INCOME TAXES NARRATIVE (Details) $ in Millions	6 Months Ended
	Jun. 30, 2018USD ($)
INCOME TAXES [Abstract]
GILTI provisional tax, net of foreign credits	$ 1.6

COMMITMENTS AND CONTINGENCIES N

COMMITMENTS AND CONTINGENCIES NARRATIVE (Details)	6 Months Ended
	Jun. 30, 2018USD ($)
Securities Class Action
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 1,750,000
shareholder derivative claim [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 250,000

RELATED PARTY TRANSACTIONS NARR

RELATED PARTY TRANSACTIONS NARRATIVE (Detail) - Broady Health Sciences - ReStore - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Feb. 28, 2013	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Related Party Transaction [Line Items]
Royalty rate	2.50%
Royalty expense		$ 93	$ 86	$ 176	$ 177
Number of days for termination notice	120 days

SUBSEQUENT EVENT - NARRATIVE (D

SUBSEQUENT EVENT - NARRATIVE (Details) - $ / shares	Jul. 18, 2018	Apr. 17, 2018	Feb. 06, 2018	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Subsequent Event [Line Items]
Common Stock, Dividends, Per Share, Declared		$ 0.14	$ 0.13	$ 1.90	$ 0.45	$ 2.03	$ 0.89
CommonStockSpecialDividendsPerShareDeclared		$ 1.76
Subsequent Event
Subsequent Event [Line Items]
Common Stock, Dividends, Per Share, Declared	$ 0.15
CommonStockSpecialDividendsPerShareDeclared	$ 0.25